Xueshuai Wan
State Key Laboratory Of Common Mechanism Research For Major Diseases, Peking Union Medical College Hospital, Peking Union Medical College And Chinese Academy Of Medical Sciences, No. 1 Shuaifuyuan
Wangfujing, 100730, China
Wangfujing, 100730, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Multiomics prediction and immunogenic validation of personalized neoantigens in cholangiocarcinoma patients.
Journal: Journal of translational medicine
Published: January 23, 2026
Lack of blood may drive liver neoplasm: a case of an intrahepatic portosystemic venous shunt and liver focal nodular hyperplasia with elevation of serum PIVKA-II level.
Journal: Hepatobiliary surgery and nutrition
Published: January 18, 2026
Patient-Derived 3D-Bioprinted Intrahepatic Cholangiocarcinoma Models Recapitulate Tumor Autologous Traits and Predict Personalized Adjuvant Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 02, 2025
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study.
Journal: Journal of hepatocellular carcinoma
Published: July 29, 2025
Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched Study.
Journal: Journal of hepatocellular carcinoma
Published: June 25, 2025
A Multi-phase CT Dataset for Automated Differential Diagnosis of Liver Tumors.
Journal: Scientific data
Published: May 09, 2025
Hepatic Subcapsular Hematoma Induced by Metastatic Tumors.
Journal: Digestive diseases and sciences
Published: March 05, 2025
Urinary biomarkers in cancer detection: explorations, advancements, challenges, and future directions.
Journal: International journal of surgery (London, England)
Published: March 04, 2025
Learning-based early detection of post-hepatectomy liver failure using temporal perioperative data: a nationwide multicenter retrospective study in China.
Journal: EClinicalMedicine
Published: November 18, 2024
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study.
Journal: Journal of hepatocellular carcinoma
Published: November 15, 2024
Research trends of cellular immunotherapy for primary liver cancer: A bibliometric analysis.
Journal: Human vaccines & immunotherapeutics
Published: November 14, 2024
Last Updated: 09/26/2026